Docetaxel-induced hand and foot syndrome in a patient with metastatic breast carcinoma
Hand and foot syndrome (HFS) is a well-known complication of chemotherapeutic drugs given in a dose-dense manner. Our patient was a 52-year-old female with metastatic breast carcinoma on salvage chemotherapy regimen with docetaxel at a dose of 60 mg/m 2 . The patient had grade 3 HFS characterized by...
Saved in:
Main Authors: | Ravichandran Gurumurthi (Author), Ramesh BV Nimmagadda (Author), Subhashini Mohan (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor attributes predicting cutaneous metastatic destiny: A report of two interesting cases
by: Ravichandran Gurumurthi, et al.
Published: (2014) -
Gemcitabine and docetaxel combination chemotherapy induced dermatomyositis associated with hand-foot syndrome
by: Mayuko Kawada, et al.
Published: (2021) -
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
by: Peng PJ, et al.
Published: (2015) -
Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients
by: Emel Emine Kayikci, et al.
Published: (2020) -
Management of cytotoxic chemotherapy-induced hand-foot syndrome
by: Johannes J.M. Kwakman, et al.
Published: (2020)